Morgan Stanley’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $647K | Sell |
248,749
-590,427
| -70% | -$1.54M | ﹤0.01% | 5336 |
|
|
2025
Q1 | $1.59M | Buy |
839,176
+460,624
| +122% | +$875K | ﹤0.01% | 4749 |
|
|
2024
Q4 | $549K | Buy |
378,552
+665
| +0.2% | +$964 | ﹤0.01% | 5381 |
|
|
2024
Q3 | $695K | Buy |
377,887
+209,971
| +125% | +$386K | ﹤0.01% | 5242 |
|
|
2024
Q2 | $168K | Buy |
167,916
+3,685
| +2% | +$3.69K | ﹤0.01% | 5750 |
|
|
2024
Q1 | $325K | Sell |
164,231
-291,749
| -64% | -$578K | ﹤0.01% | 5520 |
|
|
2023
Q4 | $711K | Buy |
455,980
+392,691
| +620% | +$613K | ﹤0.01% | 5461 |
|
|
2023
Q3 | $125K | Sell |
63,289
-55,607
| -47% | -$110K | ﹤0.01% | 5779 |
|
|
2023
Q2 | $378K | Sell |
118,896
-41,168
| -26% | -$131K | ﹤0.01% | 5356 |
|
|
2023
Q1 | $523K | Buy |
160,064
+95,566
| +148% | +$313K | ﹤0.01% | 5229 |
|
|
2022
Q4 | $324K | Buy |
64,498
+55,626
| +627% | +$280K | ﹤0.01% | 5452 |
|
|
2022
Q3 | $20K | Buy |
8,872
+8,259
| +1,347% | +$18.6K | ﹤0.01% | 6790 |
|
|
2022
Q2 | $2K | Sell |
613
-26,364
| -98% | -$86K | ﹤0.01% | 7573 |
|
|
2022
Q1 | $37K | Buy |
26,977
+9,504
| +54% | +$13K | ﹤0.01% | 6843 |
|
|
2021
Q4 | $56K | Buy |
+17,473
| New | +$56K | ﹤0.01% | 6756 |
|